Cook Medical launches debuts manufacturing facility; GE Healthcare pushes diagnostics biz in South Korea;

 @FierceMedDev: A new Abbott-related study backs up kidney stenting to lower blood pressure in patients with severe hypertension. Release | Follow @FierceMedDev

 @MarkHFierce: Another day, another lawsuit filed over DePuy's ASR metal-on-metal hip implant. More | Follow @MarkHFierce

 @DamianFierce: St. Jude is axing 300 employees and reorganizing its business units in a plan to save about $60M a year. More | Follow @DamianFierce

> Cook Medical opened its latest manufacturing facility, in Canton, IL, a $19 million production plant that will employ 60 people. News

> Cardiovate, a startup spun out of the University of Texas at San Antonio, is looking to market a stent graft the company says can prevent aneurysm leakage after heart surgery. Article

> A new project launches in Europe designed to develop a cost-effective diagnostic tool that works fast to diagnose pneumonia and other infections. Story

> MGC Diagnostics ($MGCD), formerly Angeion, boosted revenue to $6.9 million in its fiscal 2012 third quarter, up 8% from the same period last year, thanks in part to expanding international sales. Release

> GE Healthcare ($GE) is looking to expand its imaging and diagnostics presence in South Korea in response to the country's aging population. Story

> Bio-Rad ($BIO) launched a digital biology center to develop new diagnostics for inherited disorders, cancer and infectious disease. Release

> Tandem Diabetes Care has started shipping its t:slim insulin pump, a touch-screen device up to 25% slimmer than other 300-unit pumps. Item

> A new company is developing a disposable diaper sensor meant to alert nursing staff when a patient faces urinary incontinence. Story

Biotech News

 @FierceBiotech: Johns Hopkins scientists produce protein that helps track tumors. Story | Follow @FierceBiotech

 @JohnCFierce: Bellwether? IBA chief says plunge in bioassay sales in Europe reflects freeze in research activities. Report | Follow @JohnCFierce

 @RyanMFierce: Matching brain scan data with psych drugs helps improve doctor's educated guessing in prescribing depression meds. Article | Follow @RyanMFierce

> Pfizer licenses out cancer candidate to biotech VLST. Item

> FDA scrutinizes efficacy of Novartis' cystic fibrosis drug. Story

> Achillion Pharma strikes deal to raise $41.8M as hep C results loom. News

> EU hits accelerator on Ariad's leukemia drug app. Article

> Report precedes stock jump for biotech Sarepta. More

Pharma News

 @FiercePharma: Judge won't let Pfizer rid itself of inherited fen-phen scourge. Story | Follow @FiercePharma

> The drug reign in Spain is leading to lots of pain. Article

> J&J to pay states $181M to resolve Risperdal cases. Report

Suggested Articles

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.

The FDA launched a center of excellence to oversee digital health products such as smartphone apps, wearable devices and software-based treatments.

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.